Adial Pharmaceuticals/$ADIL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Adial Pharmaceuticals
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Ticker
$ADIL
Sector
Primary listing
Employees
5
Headquarters
Website
ADIL Metrics
BasicAdvanced
$2.2m
-
-$11.93
1.32
-
Price and volume
Market cap
$2.2m
Beta
1.32
52-week high
$3.67
52-week low
$1.51
Average daily volume
91k
Financial strength
Current ratio
4.425
Quick ratio
4.21
Profitability
EBITDA (TTM)
-7.799
Management effectiveness
Return on assets (TTM)
-83.20%
Return on equity (TTM)
-170.73%
Valuation
Price to book
0.33
Price to tangible book (TTM)
0.33
Price to free cash flow (TTM)
-0.16
Free cash flow yield (TTM)
-626.49%
Free cash flow per share (TTM)
-9.71
Growth
Earnings per share change (TTM)
-82.46%
3-year earnings per share growth (CAGR)
-66.52%
10-year earnings per share growth (CAGR)
-8.37%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Adial Pharmaceuticals stock?
Adial Pharmaceuticals (ADIL) has a market cap of $2.2M as of April 30, 2026.
What is the P/E ratio for Adial Pharmaceuticals stock?
The price to earnings (P/E) ratio for Adial Pharmaceuticals (ADIL) stock is 0 as of April 30, 2026.
Does Adial Pharmaceuticals stock pay dividends?
No, Adial Pharmaceuticals (ADIL) stock does not pay dividends to its shareholders as of April 30, 2026.
When is the next Adial Pharmaceuticals dividend payment date?
Adial Pharmaceuticals (ADIL) stock does not pay dividends to its shareholders.
What is the beta indicator for Adial Pharmaceuticals?
Adial Pharmaceuticals (ADIL) has a beta rating of 1.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.